Clinical trial
Safety and Efficacy Study of IV Artesunate to Treat Malaria
NCT00298610 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00298610 |
|---|---|
| Title | Safety and Efficacy Study of IV Artesunate to Treat Malaria |
| Official title | A Phase II, Open Label, Study of the Safety, Tolerability, Efficacy and Pharmacokinetics of Intravenous Artesunate in Adults With Uncomplicated Malaria |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | Military Infectious Diseases Research Program (MIDRP) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Artesunate, Malarone |
| Enrollment | 30 |
| Start date | Mar 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Mar 2, 2006 |
| Last update posted | Oct 1, 2019 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: